Treatment
Isotretinoin clinical trials
We’re tracking 11 recruiting studies that include Isotretinoin, each written for real people, not researchers, below.
Recruiting studies
- NCT07296536Enrolling by invitation
Expert views on using isotretinoin for skin rejuvenation
This study asks experienced dermatologists to share their expert opinions on using a low-dose medication (isotretinoin) for skin rejuvenation. The goal is to see if there is general agreement on how well it works and how to use it safely.
CairoAges Any age - NCT07196787Recruiting
Exercise program for people starting isotretinoin
This trial tests whether a guided exercise program helps people taking isotretinoin—a strong acne medication—manage side effects and feel better. If you're starting isotretinoin for the first time and are not currently a regular exerciser, you may be able to join.
UşakAges 18–35 - NCT07296523Enrolling by invitation
Expert views on isotretinoin for acne
This study gathers opinions from experienced dermatologists to create expert guidelines on using isotretinoin for acne. It does not test a new treatment but aims to improve how isotretinoin is prescribed.
CairoAges Any age - NCT06225570RecruitingEarly Phase 1
Weekly isotretinoin vs tetracycline for moderate acne
This trial tests a weekly dose of isotretinoin (a strong acne medicine) versus a standard tetracycline antibiotic for treating moderate acne. It aims to find a simpler, effective option with fewer side effects.
Charleston, South CarolinaAges 12 years+ - NCT06447480RecruitingPhase 3
Comparing isotretinoin to standard care for moderate acne in darker skin
This trial compares oral isotretinoin (a strong acne medication) to standard treatments for people with moderate acne and darker skin tones. It aims to find which treatment works best for skin of color.
Nice, Alpes-MaritimesAges 13–30 - NCT06485505RecruitingPhase 1
Isotretinoin vs light for nail fungus treatment
This trial compares two treatments for nail fungus (onychomycosis): a medication called isotretinoin and a special light therapy (excimer light) used alongside standard care. It aims to find which works better as an add-on treatment.
Zagazig, ZagazigAges 18–60 - NCT07481370Enrolling by invitationPhase 2
Comparing Two Medicines for Male Infertility
This study tests two medicines—isotretinoin and human chorionic gonadotropin (hCG)—to see if they can improve sperm production in men with low sperm counts or no sperm due to certain causes. It might help if you haven't responded to other treatments before.
Omaha, NebraskaAges 19–50 - NCT03126916RecruitingPhase 3
Testing added therapy for high-risk neuroblastoma in children
This Phase 3 study tests whether adding either a targeted drug (lorlatinib) or a radioactive treatment (131I-MIBG) to intensive chemotherapy improves outcomes for children with high-risk neuroblastoma. It may help by aiming at tumor cells more directly alongside standard treatment.
Birmingham, AlabamaAges 12 months–30 years - NCT06172296RecruitingPhase 3
Dinutuximab plus transplant for high-risk neuroblastoma
This trial tests adding a targeted drug called dinutuximab to standard chemotherapy, surgery, and a stem cell transplant for children and young adults with a new diagnosis of high-risk neuroblastoma. The goal is to see if this combination helps more patients stay in remission.
Birmingham, AlabamaAges Up to 30 years - NCT06942039RecruitingEarly Phase 1
Study of two drugs for young children with aggressive brain tumors
This trial tests a combination of chemotherapy drugs (topotecan given into the spine plus maintenance chemo) for children under 6 with high-risk embryonal brain tumors. The goal is to see if this approach can improve outcomes after initial treatment.
Calgary, AlbertaAges Up to 6 years - NCT07054398Recruiting
Catestatin levels in acne patients
This trial measures a blood protein called catestatin in people with moderate to severe acne. It aims to understand how catestatin relates to acne, which may help guide future treatments.
AswānAges 18–40
What Isotretinoin is being studied for
Conditions with recruiting Isotretinoin studies.
Common questions
- Are there clinical trials studying Isotretinoin?
- Yes. Clin2 currently lists 11 recruiting studies that include Isotretinoin, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Isotretinoin trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Isotretinoin an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Isotretinoin or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.